STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGON
  4. [144] CG Oncology, Inc. SEC Filing

CGON (CGON) insider files to sell 4,303 shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CGON filed a notice of proposed sales of common stock. The filing lists 4,303 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, tied to a stock option exercise with an intended sale date of July 29, 2026 on NASDAQ.

Over the prior three months, Ambaw Bellete is reported as having sold several large common stock blocks: 50,000 shares on July 15, 23, and 27, 2026 and 52,438 shares on July 15, 2026, with disclosed gross proceeds amounts for each sale.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 4,303 shares Common stock proposed for sale related to stock option exercise on July 29, 2026
Gross proceeds 07/28/2026 $3,625,195.00 Sale of 50,000 common shares by Ambaw Bellete on July 28, 2026
Gross proceeds 07/27/2026 $3,627,995.00 Sale of 50,000 common shares by Ambaw Bellete on July 27, 2026
Gross proceeds 07/23/2026 $3,588,620.00 Sale of 50,000 common shares by Ambaw Bellete on July 23, 2026
Gross proceeds 07/15/2026 $3,816,007.65 Sale of 52,438 common shares by Ambaw Bellete on July 15, 2026
Shares sold 07/28/2026 50,000 shares Common stock sold by Ambaw Bellete on July 28, 2026
Shares sold 07/27/2026 50,000 shares Common stock sold by Ambaw Bellete on July 27, 2026
Shares sold 07/23/2026 50,000 shares Common stock sold by Ambaw Bellete on July 23, 2026
Form 144 regulatory
"CGON’s Form 144 filing reports a proposed sale of common shares."
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
stock option exercise financial
"The 4,303 shares are tied to a stock option exercise dated July 29, 2026."
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Executive Financial Services financial
"The sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services."
gross proceeds financial
"Each prior sale lists the number of shares and related gross proceeds."
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does CGON’s Form 144 filing disclose about upcoming stock sales?
The filing reports a proposed sale of 4,303 common shares of CGON stock, to be sold via Morgan Stanley Smith Barney LLC Executive Financial Services, related to a stock option exercise on July 29, 2026.

Who is the selling security holder in CGON’s Form 144 filing?
The filing identifies Ambaw Bellete, with an address in Dallas, Texas, as the selling security holder. The document lists multiple past sales of CGON common stock associated with this individual over the prior three months.

How many CGON shares are proposed to be sold under this Form 144?
The notice covers a proposed sale of 4,303 common shares of CGON. These shares are tied to a stock option exercise and are expected to be sold on July 29, 2026 through a brokerage arrangement.

What past CGON stock sales by Ambaw Bellete are disclosed?
The filing lists four prior sales: 50,000 shares on July 28, 2026, 50,000 on July 27, 2026, 50,000 on July 23, 2026, and 52,438 on July 15, 2026, each with reported gross proceeds amounts.

Which broker is handling the proposed CGON share sale in this Form 144?
The proposed sale of 4,303 CGON common shares is listed under Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR